Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Jan-22 5:14 PM View:  | Dentzer James E President & CEO Director | Curis Inc. (CRIS) | 31-Jan-22 | Sale (Planned) | 3,094 | $3.07 | $9,498.58 | (5%) 67.97K to 64.88K | |
| 31-Jan-22 5:14 PM View: | Dentzer James E President & CEO Director | Curis Inc. (CRIS) | 27-Jan-22 | Sale | 2,406 | $3.18 | $7,651.08 | (3%) 70.38K to 67.97K | |
| 26-Jan-21 6:20 PM View: | Dentzer James E President & CEO Director | Curis Inc. (CRIS) | 26-Jan-21 | Market Sale (Planned) | 3,094 | $10.59 | $32,758.00 | (4%) 70.36K to 67.27K | 3% |
| 26-Jan-21 6:20 PM View: | Dentzer James E President & CEO Director | Curis Inc. (CRIS) | 25-Jan-21 | Market Sale | 2,283 | $10.96 | $25,021.70 | (3%) 72.64K to 70.36K | 6% |
| 24-Jan-20 6:10 PM View: | Dentzer James E President & CEO Director | Curis Inc. (CRIS) | 24-Jan-20 | Market Sale (Planned) | 3,094 | $1.64 | $5,076.33 | (7%) 45.25K to 42.16K | (411%) |
| 24-Jan-20 6:10 PM View: | Dentzer James E President & CEO Director | Curis Inc. (CRIS) | 23-Jan-20 | Market Sale | 3,658 | $1.69 | $6,181.65 | (7%) 48.91K to 45.25K | (396%) |
| 25-Jan-19 4:40 PM View: | Dentzer James E President & CEO Director | Curis Inc. (CRIS) | 24-Jan-19 | Market Sale (Planned) | 3,094 | $1.16 | $3,576.97 | (7%) 44.73K to 41.64K | (622%) |
| 25-Jan-19 4:38 PM View: | Kunkel Lori Anne Director | Curis Inc. (CRIS) | 23-Jan-19 | Market Sale (Planned) | 14,800 | $1.05 | $15,581.40 | (40%) 37.0K to 22.2K | (693%) |
| 25-Jan-19 4:40 PM View: | Dentzer James E President & CEO Director | Curis Inc. (CRIS) | 23-Jan-19 | Market Sale (Planned) | 2,397 | $1.09 | $2,612.73 | (5%) 47.13K to 44.73K | (666%) |
| 25-Jan-19 4:38 PM View: | Rubin Marc Director | Curis Inc. (CRIS) | 23-Jan-19 | Market Sale (Planned) | 18,500 | $1.05 | $19,476.80 | (39%) 47.32K to 28.82K | (693%) |
| 25-Jan-19 4:40 PM View: | Martell Robert Head of Research & Development | Curis Inc. (CRIS) | 23-Jan-19 | Payment of Exercise | 8,473 | $1.07 | $9,066.11 | (23%) 37.0K to 28.53K | (681%) |
| 25-Jan-19 4:39 PM View: | Greenacre Martyn D Director | Curis Inc. (CRIS) | 23-Jan-19 | Market Sale (Planned) | 18,500 | $1.05 | $19,475.00 | (41%) 44.59K to 26.09K | (693%) |
| 25-Jan-19 4:40 PM View: | Martell Robert Head of Research & Development | Curis Inc. (CRIS) | 23-Jan-19 | Market Sale (Planned) | 5,500 | $1.07 | $5,900.40 | (19%) 28.53K to 23.03K | (679%) |
| 25-Jan-19 4:37 PM View: | Kaitin Kenneth I Director | Curis Inc. (CRIS) | 23-Jan-19 | Market Sale (Planned) | 14,800 | $1.05 | $15,587.40 | (34%) 42.92K to 28.12K | (693%) |
| 24-Jan-18 4:43 PM View: | Greenacre Martyn D Director | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 185,000 | -- | -- | 488% 37.95K to 222.94K | |
| 24-Jan-18 4:36 PM View: | Dentzer James E Chief Financial Officer | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 206,250 | -- | -- | 3580% 5.76K to 212.01K | |
| 24-Jan-18 4:45 PM View: | Rubin Marc Director | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 185,000 | -- | -- | 359% 51.6K to 236.6K | |
| 24-Jan-18 4:39 PM View: | Tuck David Chief Medical Officer | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 133,750 | -- | -- | 375% 35.67K to 169.42K | |
| 24-Jan-18 5:02 PM View: | Martell Robert Director | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 185,000 | -- | -- | 100% 0 to 185.0K | |
| 24-Jan-18 4:47 PM View: | Kunkel Lori Anne Director | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 185,000 | -- | -- | 100% 0 to 185.0K | |
| 24-Jan-18 4:44 PM View: | Kaitin Kenneth I Director | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 185,000 | -- | -- | 625% 29.61K to 214.61K | |
| 24-Jan-18 4:35 PM View: | Fattaey Ali Ph.D. President & CEO Director | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 206,250 | -- | -- | 178% 115.89K to 322.14K | |
| 16-Nov-17 2:02 PM View: | Rubin Marc Director | Curis Inc. (CRIS) | 16-Nov-17 | Market Purchase | 25,000 | $0.98 | $24,500.00 | 94% 26.6K to 51.6K | 70% |
| 15-Nov-17 10:24 AM View: | Fattaey Ali Ph.D. President & CEO Director | Curis Inc. (CRIS) | 15-Nov-17 | Market Purchase | 50,000 | $1.06 | $53,000.00 | 76% 65.89K to 115.89K | 58% |
| 02-Jun-17 4:33 PM View: | Greenacre Martyn D Director | Curis Inc. (CRIS) | 31-May-17 | Option Exercise | 15,000 | $1.39 | $20,850.00 | 43% 35.14K to 50.14K | |
| 02-Jun-17 4:31 PM View: | Kaitin Kenneth I Director | Curis Inc. (CRIS) | 31-May-17 | Payment of Exercise | 12,193 | $1.71 | $20,850.00 | (29%) 41.8K to 29.61K | 2% |
| 02-Jun-17 4:33 PM View: | Greenacre Martyn D Director | Curis Inc. (CRIS) | 31-May-17 | Payment of Exercise | 12,193 | $1.71 | $20,850.00 | (24%) 50.14K to 37.95K | 2% |
| 02-Jun-17 4:31 PM View: | Kaitin Kenneth I Director | Curis Inc. (CRIS) | 31-May-17 | Option Exercise | 15,000 | $1.39 | $20,850.00 | 56% 26.8K to 41.8K | |
| 05-May-17 4:30 PM View: | McNab James R Director | Curis Inc. (CRIS) | 05-May-17 | Market Sale (Planned) | 16,176 | $1.90 | $30,721.50 | (2%) 945.86K to 929.69K | 12% |
| 05-May-17 4:30 PM View: | McNab James R Director | Curis Inc. (CRIS) | 04-May-17 | Market Sale (Planned) | 30,100 | $1.97 | $59,158.50 | (3%) 975.96K to 945.86K | 15% |
| 05-May-17 4:30 PM View: | McNab James R Director | Curis Inc. (CRIS) | 03-May-17 | Market Sale (Planned) | 30,000 | $2.18 | $65,544.00 | (3%) 1.01M to 975.96K | 23% |
| 02-May-17 4:53 PM View: | McNab James R Director | Curis Inc. (CRIS) | 02-May-17 | Market Sale (Planned) | 35,646 | $2.31 | $82,313.70 | (22%) 161.92K to 126.28K | 28% |
| 02-May-17 4:53 PM View: | McNab James R Director | Curis Inc. (CRIS) | 01-May-17 | Market Sale (Planned) | 38,113 | $2.38 | $90,708.90 | (19%) 200.03K to 161.92K | 30% |
| 02-May-17 4:53 PM View: | McNab James R Director | Curis Inc. (CRIS) | 28-Apr-17 | Market Sale (Planned) | 42,949 | $2.45 | $105,015.00 | (18%) 242.98K to 200.03K | 32% |
| 27-Apr-17 4:58 PM View: | McNab James R Director | Curis Inc. (CRIS) | 27-Apr-17 | Market Sale (Planned) | 37,202 | $2.57 | $95,624.00 | (3%) 1.16M to 1.12M | 35% |
| 27-Apr-17 4:58 PM View: | McNab James R Director | Curis Inc. (CRIS) | 26-Apr-17 | Market Sale (Planned) | 19,814 | $2.65 | $52,441.70 | (2%) 1.18M to 1.16M | 37% |
| 27-Apr-17 4:58 PM View: | McNab James R Director | Curis Inc. (CRIS) | 26-Apr-17 | Market Sale (Planned) | 32,738 | $2.65 | $86,647.70 | (3%) 1.21M to 1.18M | 37% |
| 27-Apr-17 4:58 PM View: | McNab James R Director | Curis Inc. (CRIS) | 25-Apr-17 | Market Sale (Planned) | 56,940 | $2.60 | $148,306.00 | (4%) 1.27M to 1.21M | 36% |
| 24-Apr-17 5:03 PM View: | McNab James R Director | Curis Inc. (CRIS) | 24-Apr-17 | Market Sale (Planned) | 42,076 | $2.56 | $107,862.00 | (3%) 1.31M to 1.27M | 35% |
| 24-Apr-17 5:03 PM View: | McNab James R Director | Curis Inc. (CRIS) | 21-Apr-17 | Market Sale (Planned) | 45,705 | $2.58 | $117,841.00 | (3%) 1.36M to 1.31M | 35% |
| 24-Apr-17 5:03 PM View: | McNab James R Director | Curis Inc. (CRIS) | 20-Apr-17 | Market Sale (Planned) | 22,541 | $2.66 | $59,979.30 | (2%) 1.38M to 1.36M | 37% |
| 09-Sep-16 12:49 PM View: | Aurigene Discovery Technolo... 10% Owner | Curis Inc. (CRIS) | 07-Sep-16 | Purchase | 10,208,300 | $2.40 | $24,500,000.00 | 60% 17.12M to 27.33M | |
| 27-May-16 5:04 PM View: | Greenacre Martyn D Director | Curis Inc. (CRIS) | 27-May-16 | Market Option Sale | 15,000 | $1.69 | $25,350.00 | (30%) 50.18K to 35.18K | 1% |
| 27-May-16 5:04 PM View: | Greenacre Martyn D Director | Curis Inc. (CRIS) | 27-May-16 | Option Exercise | 15,000 | $1.67 | $25,050.00 | 43% 35.18K to 50.18K | < 1% |
| 27-May-16 5:02 PM View: | Kaitin Kenneth I Director | Curis Inc. (CRIS) | 26-May-16 | Option Exercise | 15,000 | $1.67 | $25,050.00 | 56% 26.8K to 41.8K | < 1% |
| 27-May-16 5:02 PM View: | Kaitin Kenneth I Director | Curis Inc. (CRIS) | 26-May-16 | Market Option Sale | 15,000 | $1.76 | $26,400.00 | (36%) 41.8K to 26.8K | 5% |
| 07-Jan-16 5:03 PM View: | Passeri Daniel R Director | Curis Inc. (CRIS) | 06-Jan-16 | Option Exercise | 12,900 | $1.57 | $20,253.00 | 6% 198.9K to 211.8K | |
| 30-Dec-15 7:58 PM View: | Passeri Daniel R Director | Curis Inc. (CRIS) | 30-Dec-15 | Option Exercise | 14,400 | $1.57 | $22,608.00 | 7% 198.9K to 213.3K | |
| 30-Dec-15 7:58 PM View: | Passeri Daniel R Director | Curis Inc. (CRIS) | 30-Dec-15 | Market Option Sale | 14,400 | $3.01 | $43,344.00 | (7%) 213.3K to 198.9K | 44% |
| 30-Dec-15 7:58 PM View: | Passeri Daniel R Director | Curis Inc. (CRIS) | 29-Dec-15 | Option Exercise | 11,200 | $1.57 | $17,584.00 | 6% 198.9K to 210.1K |
